The Albany Gazette - Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025

NYSE - LSE

RIO	1.42%	94.21	$
BTI	0.54%	52.64	$
GSK	-0.32%	47.03	$
BCE	-0.96%	19.73	$
RELX	-0.21%	33.42	$
RBGPF	0.14%	65.09	$
CMSC	0.4%	20.24	$
BP	0.65%	44.79	$
NGG	1.04%	76.12	$
CMSD	0.44%	20.43	$
BCC	0.39%	74.99	$
AZN	-0.51%	156.9	$
VOD	2.62%	16.82	$
JRI	1.19%	10.9	$
RYCEF	0.62%	19.42	$

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025

BOULEVARD 29.01.2025

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025

CAMBRIDGE, MA / ACCESS Newswire / January 29, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 14, 2025 to report its fourth quarter and full year 2024 financial results, and provide a corporate update.

Text size:

A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.

Webcast: https://investors.modernatx.com

The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.

About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

(L.Thomas--TAG)

Featured

'Verity' kills, Cruise bombs in N. American movie theaters

The bookish thriller "Verity" cleaned up in its North American box office debut this weekend while Tom Cruise flopped in "Digger" playing a rich old guy who thinks he can save the world.

US prison chief who oversaw botched execution resigns

The prison chief in the southern US state of Tennessee has resigned, the governor said Saturday, after an unprecedented botched execution left a convicted murderer on a ventilator in critical condition.

Turkey football ref chief jailed pending trial for graft

The Turkish Football Federation (TFF) said Saturday it was working to shake up its refereeing oversight body after its top official was jailed pending trial on graft charges.

Man City whistleblower Rui Pinto facing 'dire consequences' - lawyers

Computer hacker Rui Pinto, the man behind the Football Leaks website which helped trigger the Premier League probe into Manchester City's finances, faces "dire consequences" after having his protected witness status removed, his lawyers said on Friday.